| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1235 | Cay10397 | Selective inhibitor of 15-hydroxy PGDH, significantly suppressing endogenous 11-oxo-ETE production with a corresponding increase in 11(R)-HETE |
|
| DCC1236 | Cay10398 | Isoform-selective inhibitor of histone deacetylase (HDAC1) |
|
| DCC1237 | Cay10633 | Novel potent CysLT2 receptor antagonist |
|
| DCC1238 | Caylin-1 | Novel Mdm2 inhibitor, an analog of Nutlin-3 |
|
| DCC1239 | Caylin-2 | Novel Mdm2 inhibitor, an analog of Nutlin-3 |
|
| DCC1240 | Cb14171361 | Novel RAF kinase inhibitor |
|
| DCC1241 | Cb14280993 | Novel SRC kinase inhibitor |
|
| DCC1242 | Cb15143266 | Novel IκB kinase inhibitor |
|
| DCC1243 | Cb17846240 | Novel Thymidine kinase (TK) inhibitor |
|
| DCC1244 | Cb20372475 | Novel Cyclin-dependent kinase inhibitor |
|
| DCC1245 | Cb28324237 | Novel IκB kinase inhibitor |
|
| DCC1246 | Cb300919 | Novel Cell_cycle>cell cycle inhibitor |
|
| DCC1247 | cb3717 | Dual thymidylate synthase and dihydrofolate reductase inhibitor |
|
| DCC1248 | Cb5255829 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1249 | cb5468139 | Selective sphingosine kinase 1 (SK1) inhibitor |
|
| DCC1250 | Cb5660386 | Novel inhibitor of HIV-1 entry |
|
| DCC1251 | Cb6513745 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1252 | Cb7833407 | Selective inhibitor of Adenylyl Cyclase isoform-2 (AC2) |
|
| DCC1253 | Cb-892 | Novel inhibitor of HIV-1 gene expression |
|
| DCC1254 | Cb9029936 | Novel potent inhibitor of filamentation and biofilm formation by the Candida albicans SC5314 strain |
|
| DCC1255 | Cb9125618 | Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
|
| DCC1256 | Cb97929926 | Novel Protein kinase A and B inhibitor |
|
| DCC1257 | Cbap-bpyne | The first clickable, photoreactive probe that inhibits both γ-secretase and PSase activities and specifically labels PS1-NTF and signal peptide peptidase (SPP) |
|
| DCC1258 | Cbb1007 | Novel cell-permeable, potent, reversible, and substrate competitive LSD1 inhibitor, promoting the adipogenic differentiation of hESCs |
|
| DCC1259 | Cbl0100 | Novel inhibitor of viral transcriptional elongation, blocking both HIV-1 replication and reactivation |
|
| DCC1260 | CBL0137 hydrochloride Featured | CBL0137 (CBL-0137) activates p53 and inhibits NF-kB with EC50s of 0.37 μM and 0.47 μM in the cell-based p53 and NF-kB reporter assays, respectively. It also inhibits histone chaperone FACT (facilitates chromatin transcription complex). |
|
| DCC1261 | Cbn207192 | Novel selective inhibitor of KDM4s, inhibiting all members of the KDM4(A-E) subfamily |
|
| DCC1262 | Cbn209350 | Novel KDM4 inhibitor, inhibiting equally all members of the KDM4 family and exhibiting modest selectivity over other JmjC-KDMs including KDM2A and PHF8 |
|
| DCC1263 | Cbs-3595 | Novel Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα -related Diseases |
|
| DCC1264 | Cbtf-ee | The first Gatekeeper RXR antagonist that does not show allosteric inhibition in permissive RXR heterodimers, binding domain (LBD) at the entrance of the ligand binding pocket (LBP), blocking access to the LBP and thus serving as a gatekeeper |
|
